Form 4 Tracker
UNITED THERAPEUTICS Corp
UTHR

260 insider filings · Latest: Oct 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 20, 2026Jul 21 8:35 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$531.69$5.1M324,443(I)

View →

Jul 17, 2026Jul 20 8:32 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$537.05$5.1M324,443(I)

View →

Jul 16, 2026Jul 17 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$530.91$5.0M324,443(I)

View →

Jul 15, 2026Jul 16 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$530.35$5.0M324,443(I)

View →

Jul 16, 2026Jul 16 8:30 PMPaul A MahonEVP & GENERAL COUNSEL
Sale
8,300$533.69$4.4M45,172(D)

View →

Jul 16, 2026Jul 16 8:17 PMPAUL A. MAHON
Proposed Sale
8,300$533.69$4.4M—

View →

Jul 14, 2026Jul 15 9:00 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$526.83$5.0M40,513(D)

View →

Jul 13, 2026Jul 14 8:34 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$535.99$5.1M40,513(D)

View →

Jul 10, 2026Jul 13 8:33 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$544.60$5.2M40,513(D)

View →

Jul 10, 2026Jul 10 8:03 PMJAN MALCOLM
Proposed Sale
325$550.59$178.9K—

View →

Jul 10, 2026Jul 10 8:02 PMJan MalcolmDirector
Sale
325$550.59$178.9K450(D)

View →

Jul 9, 2026Jul 10 1:26 AMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$551.13$5.2M40,513(D)

View →

Jul 8, 2026Jul 9 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$553.17$5.3M40,513(D)

View →

Jul 7, 2026Jul 8 8:47 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$558.87$5.3M40,513(D)

View →

Jul 6, 2026Jul 7 1:10 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$548.96$5.2M40,513(D)

View →

Jul 2, 2026Jul 2 9:47 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$554.61$5.3M40,513(D)

View →

Jul 2, 2026Jul 2 8:32 PMPaul A MahonEVP & GENERAL COUNSEL
Sale
8,300$552.56$4.6M45,172(D)

View →

Jul 1, 2026Jul 2 8:31 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$543.66$5.2M40,513(D)

View →

Jul 2, 2026Jul 2 8:13 PMPAUL MAHON
Proposed Sale
8,300$552.56$4.6M—

View →

Jul 1, 2026Jul 1 8:52 PMMARTINE ROTHBLATT
Proposed Sale
209,000$541.83$113.2M—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 15, 2023Feb 26 9:30 PMJames EdgemondCFO AND TREASURER
Grant/Award
77,648$217.5010,380(D)

View →

Feb 25, 2026Feb 25 9:31 PMChristopher CauseyDirector
Option Exercise
1,000$119.766,320(D)

View →

Feb 23, 2026Feb 24 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
14,440$146.030(I)

View →

Feb 19, 2026Feb 19 9:31 PMPaul A MahonEVP & GENERAL COUNSEL
Option Exercise
8,300$146.0341,800(D)

View →

Feb 17, 2026Feb 18 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.035,065(I)

View →

Feb 9, 2026Feb 10 9:30 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.0312,940(I)

View →

Feb 5, 2026Feb 5 9:31 PMPaul A MahonEVP & GENERAL COUNSEL
Option Exercise
8,300$146.0350,100(D)

View →

Feb 2, 2026Feb 3 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.0320,815(I)

View →

Jan 26, 2026Jan 28 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.0328,690(I)

View →

Jan 20, 2026Jan 28 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
7,875$146.0336,565(I)

View →

Jan 20, 2026Jan 28 9:30 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
14,625$146.0367,875(I)

View →

Jan 21, 2026Jan 23 9:32 PMKevin TraceyDirector
Grant/Award
1,220—1,220(D)

View →

← Previous

Page 13 of 13